David Tapolczay

David Joszef Tapolczay was the founder of Sigma Entity One Ltd., founded in 2003, where the title held was Chairman & Chief Executive Officer.
Dr. Tapolczay was the founder of Nuformix Technologies Ltd., founded in 2007, with the title Non-Executive Chairman from 2007 to 2020.
Dr. Tapolczay was the founder of Nuformix Plc, founded in 2008, with the title Non-Executive Chairman from 2008 to 2020.
Dr. Tapolczay is the founder of CDT Equity, Inc., founded in 2021, holding the title Head-Strategy & Licensing starting in 2025.
Current jobs include Chief Executive Officer at Medeor Pharma Ltd. since 2006, Director at Medeor Old Ltd., and Director at Medeor LLP.
Former jobs include Chief Executive Officer at The Medical Research Council; Chief Executive Officer at Lifearc from 2008 to 2018; Chief Executive Officer at Stylacats Ltd.; Chief Executive Officer at St George Street Capital Ltd. from 2018 to 2023; Non-Executive Chairman at Intelligent OMICS Ltd.; Director at Bicycle Therapeutics Plc; Director at Nanoform Cardiovascular Therapeutics Ltd.; Manager at Zeneca Agrochemicals in 2013; Executive Vice President-Research & Development at Cambridge Discovery Chemistry; Senior Manager-Chemical Development at Glaxo Smithkline Plc; Vice President-Technology Development at GSK Pharmaceutical Trading SA from 2005 to 2007; Senior Vice President-Pharmaceutical Sciences at Millenium Group Ltd.; Chief Scientific Officer at Sigma-Aldrich Co. Ltd.; Vice President-Technology Development at GSK Group Ltd. Education includes undergraduate and doctorate degrees from Southampton Business School.